Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

BBIO Price Correlated With Financials For Bridgebio Pharma

See how revenue, income, cash flow, and balance sheet financials have changed over 7 quarters since 2020. Compare with BBIO stock chart to see long term trends.

BBIO Stock Compared to Quarterly

BBIO Income Statement

Revenue, Net:2344000
Cost of Goods & Services Sold:1454000
Selling, General & Admin Expense:46084000
Research & Development Expense:104305000
Total Operating Expenses:151843000
Operating Income:-149499000
Income Taxes:0
Net Income:-161016000
Earnings Per Share, Basic:-1.06
Shares Outstanding, Basic Avg:147166573
Revenue Per Share:0.0159

BBIO Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-121561000
Net Cash from Operations Per Share:-0.826
Repurchases/Buybacks Common Stock:143150000
Net Cash from Financing Activities:-135456000
Property, Plant & Equipment Purchases:6462000
Net Cash from Investing Activities:58968000
Net Change in Cash & Equivalents:-198049000

BBIO Balance Sheet

Cash and Cash Equivalents:183079000
Short-Term Investments:419264000
Accounts Receivable, Net:null
Total Current Assets:639710000
Property, Plant & Equipment, Net:27741000
Total Assets:781524000
Accounts Payable:12035000
Current Portion of Long-Term Debt:null
Total Short-Term Liabilities:95823000
Long Term Debt, Non-Current Portion:103138000
Total Liabilities:1517398000

Insider Trading

Change
Value
Transaction
SEC Form 4
Dachille Douglas A.   Director
10,000 sh at $16
$163,650
Buy
SAUNDERS BRENT L   Director
17,600 sh at $14
$254,880
Buy
Lo Andrew   Director
7,500 sh at $13
$98,850
Buy
Valantine Hannah   Director
1,764 sh at $14
$25,102
Buy
DANIELS RONALD J   Director
10,402 sh at $14
$148,343
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Kohlberg Kravis Roberts & Co. L.P.
31,060,971 sh
 
$1,455,828
Viking Global Investors Lp
26,620,991 sh
 
$1,247,726
Blackrock Inc.
10,141,311 sh
640,990 sh
7%
$475,323
-$103,817
Vanguard Group Inc
9,435,412 sh
-1,893,717 sh
-17%
$442,238
-$248,385
Perceptive Advisors LLC
7,756,928 sh
 
$363,567
Aisling Capital Management Lp
6,068,125 sh
 
$284,413
Hillhouse Capital Advisors, Ltd.
5,362,014 sh
 
$251,318
State Street Corp
3,083,859 sh
430,363 sh
16%
$144,540
-$17,217
Janus Henderson Group Plc
2,645,441 sh
-165,211 sh
-6%
$123,992
-$47,345
Geode Capital Management, LLC
1,947,085 sh
123,147 sh
7%
$91,259
-$19,928
SC US (Ttgp), Ltd.
1,860,364 sh
 
$87,195
Cormorant Asset Management, Lp
1,768,909 sh
-112,071 sh
-6%
$82,909
-$31,756
FMR LLC
1,688,150 sh
301,462 sh
22%
$79,123
-$5,409
JPMorgan Chase & Co
1,454,188 sh
-158,767 sh
-10%
$68,159
-$30,167
Northern Trust Corp
1,115,399 sh
37,336 sh
3%
$52,279
-$13,440
Charles Schwab Investment Management Inc
1,047,492 sh
320,410 sh
44%
$49,096
$4,773
Rockefeller Capital Management L.P.
836,914 sh
4,830 sh
1%
$39,224
-$11,498
Lord, Abbett & Co. LLC
796,668 sh
-25,350 sh
-3%
$37,340
-$12,770
Gilder Gagnon Howe & Co LLC
755,322 sh
-2,651 sh
0%
$35,402
-$10,804
Affinity Asset Advisors, LLC
654,435 sh
104,435 sh
19%
$30,673
-$2,855

Data imported from Bridgebio Pharma Inc SEC filings. Check original filings before making any investment decision.